Pablo Ryan, MD PhD

Hospital Universitario Infanta Leonor, Universidad Complutense de Madrid
Madrid, Madrid, Spain

Gilead Sciences, Inc (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member)

Presentation(s):

• LB1 - Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

  Thursday, September 30, 2021
  5:15 PM - 5:30 PM EDT